Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.
Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023. Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023. Moneycontrol Latest News Read More
